CLL patients exhibit a dysregulated necroptosis mechanism due to RIPK3 and cylindromatosis (CYLD) downregulation, which may explain why malignant B cells accumulate in CLL patients [34]. This evidence concerns the gene RIPK3 and B-cell chronic lymphocytic leukemia.